CK Life Sciences International (Holdings), Inc. (HK:0775) has released an update.
CK Life Sciences International announces significant leadership changes: Mr. Lance Richard Lee Yuen is appointed as the new Executive Director, Vice President, and CEO starting from September 20, 2024. Concurrently, Mr. Yu Ying Choi, Alan Abel, formerly the CEO, will transition to the role of Deputy Chairman. Both executives bring extensive experience to their roles, with Mr. Yuen having over 35 years of international leadership in healthcare and pharmaceuticals, and Mr. Yu having a long-standing history with the company.
For further insights into HK:0775 stock, check out TipRanks’ Stock Analysis page.
